Breast Cancer (Locally Advanced or Metastatic) Clinical Trials

6 recruitingLast updated: June 17, 2026

There are 6 actively recruiting breast cancer (locally advanced or metastatic) clinical trials across 3 countries. Studies span Phase 1, Phase 2, Not Applicable. Top locations include Beijing, Beijing Municipality, China, Bhubaneswar, Odisha, India, Boston, Massachusetts, United States. Updated daily from ClinicalTrials.gov.


Breast Cancer (Locally Advanced or Metastatic) Trials at a Glance

6 actively recruiting trials for breast cancer (locally advanced or metastatic) are listed on ClinicalTrialsFinder across 6 cities in 3 countries. The largest study group is Phase 1 with 4 trials, with the heaviest enrollment activity in Beijing, Bhubaneswar, and Boston. Lead sponsors running breast cancer (locally advanced or metastatic) studies include All India Institute of Medical Sciences, Bhubaneswar, Beijing Biotech, and Essen Biotech.

Browse breast cancer (locally advanced or metastatic) trials by phase

Treatments under study

About Breast Cancer (Locally Advanced or Metastatic) Clinical Trials

Looking for clinical trials for Breast Cancer (Locally Advanced or Metastatic)? There are currently 6 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Breast Cancer (Locally Advanced or Metastatic) trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Breast Cancer (Locally Advanced or Metastatic) clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 16 of 6 trials

Recruiting
Phase 1Phase 2

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Antitumor Activity of INV-6452 in Adult Patients With Hormone Receptor Positive, Human Epidermal Growth Factor Receptor 2 Negative (HR+/HER2-) Advanced/Metastatic Breast Cancer or Locally Advanced/Metastatic Solid Tumor

Ovarian CancerEndometrial CancerBreast Cancer (Locally Advanced or Metastatic)+2 more
Shenzhen Ionova Life Sciences Co., Ltd.201 enrolled1 locationNCT07612891
Recruiting
Not Applicable

Remote Monitoring and Symptom Management Digital Application

Colorectal, CancerBreast Cancer (Locally Advanced or Metastatic)Lymphoma
Patrick C. Johnson, MD60 enrolled1 locationNCT07553572
Recruiting
Phase 1Phase 2

Dual-Target CAR-NK Cells for Advanced Breast Cancer (HER2+ and TNBC)

HER2-positive Breast CancerTriple Negative Breast Cancer(TNBC)Breast Cancer (Locally Advanced or Metastatic)
Beijing Biotech60 enrolled1 locationNCT07486089
Recruiting
Not Applicable

Tumor Margin Skin Tattooing Before Neo-adjuvant Chemotherapy in Patients With Breast Cancer

Breast Cancer (Locally Advanced or Metastatic)Neoadjuvant ChemoimmunotherapyTattoo Skin Markers
All India Institute of Medical Sciences, Bhubaneswar30 enrolled1 locationNCT07478900
Recruiting
Phase 1Phase 2

EBNK-001 Allogeneic NK Cells With Low-Dose IL-15 ± Pembrolizumab in Advanced Solid Tumors

Colorectal, CancerEsophageal CancerOvarian Cancer+12 more
Essen Biotech83 enrolled1 locationNCT07410676
Recruiting
Phase 1

A Study of SH009 Injection in Patients With Advanced Solid Tumors.

Esophageal CancerBreast Cancer (Locally Advanced or Metastatic)Lung Cancer (NSCLC)+4 more
Nanjing Sanhome Pharmaceutical, Co., Ltd.150 enrolled1 locationNCT07390838